Newer approaches to androgen deprivation therapy in prostate cancer

By Pitts W.R.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 882-882

Elsevier

Access to resources Recommend Favorite

Clinical Outcome of Patients with Lymph Node Positive Prostate Cancer after Radical Prostatectomy versus Androgen Deprivation

By Grimm M.-O.   Kamphausen S.   Hugenschmidt H.   Stephan-Odenthal M.   Ackermann R.   Vogeli T.A.  

European Urology, Vol. 41, Iss. 6, 2002-06 ,pp. : 628-634

Elsevier

Access to resources Recommend Favorite

Androgen deprivation therapy for prostate cancer results in significant loss of bone density

By Wei J.T.   Gross M.   Jaffe C.A.   Gravlin K.   Lahaie M.   Faerber G.J.   Cooney K.A.  

Urology, Vol. 54, Iss. 4, 1999-10 ,pp. : 607-611

Elsevier

Access to resources Recommend Favorite

Prolonged neoadjuvant combined androgen blockade leads to a further reduction of prostatic tumor volume: three versus six months of endocrine therapy - a possible molecular mechanism for androgen deprivation therapy failure in prostate cancer

By van der Kwast T.H.   Tetu B.   Candas B.   Gomez J.-L.   Cusan L.   Labrie F.  

Urology, Vol. 53, Iss. 3, 1999-03 ,pp. : 523-529

Elsevier

Access to resources Recommend Favorite

Effects of androgen deprivation on prostate alpha 1 -adrenergic receptors

By Lacey J.P.   Donatucci C.F.   Price D.T.   Page S.O.   Bennett S.A.L.   Tenniswood M.P.   Schwinn D.A.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 335-341

Elsevier

Access to resources Recommend Favorite